Loading clinical trials...
Loading clinical trials...
Phase Ib Trial of Dose-escalating AZD1775 in Combination With Concurrent Radiation and Cisplatin for Intermediate and High Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Conditions
Interventions
AZD1775
Cisplatin
+1 more
Locations
1
United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Start Date
October 26, 2015
Primary Completion Date
June 14, 2019
Completion Date
June 23, 2021
Last Updated
June 29, 2021
NCT03485209
NCT02296684
NCT03509012
NCT02383966
NCT02822482
NCT02658214
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions